The Medicines for Human Use (Clinical Trials) (Amendment) Regulations 2024 were officially signed into law on 10 April 2025, marking a significant development in the UK clinical trials framework ...

along with its partner Moffitt Cancer Center ("Moffitt"), has received approval for an amendment to the protocol governing its ongoing clinical trial using CAR-T therapy for the treatment of ...

New Delhi: The government has framed standard operating procedures (SOPs) for clinical research organizations in the country to ensure safe clinical trials. Till date, the functions of these ...

HG-CT-1 is the Company's CAR-T therapy, currently undergoing clinical trials in adults for the treatment of R/R AML. This amendment, filed with the U.S. Food and Drug Administration (FDA), seeks ...

Following the rules, Ms. Dave said New Drugs and Clinical Trials (Amendment) Rules were notified in 2024 to streamline the approval process for clinical trials and new drugs in India which aimed ...

These new rules, called the New Drugs and Clinical Trials (Amendment) Rules, 2024, come into force 1 April 2025. They define a clinical research organization “as the sponsor or a body ...

Anixa Biosciences (ANIX) announced that it, along with its partner Moffitt Cancer Center, has received approval for an amendment to the protocol governing its ongoing clinical trial using CAR-T ...

today announced that it and partner Moffitt Cancer Center ("Moffitt") have submitted an amendment to the current protocol that governs its ongoing clinical trial utilizing a CAR-T therapy to treat ...

a biotechnology company focused on the treatment and prevention of cancer announced that it along with its partner Moffitt Cancer Center (Moffitt), has received approval for an amendment to the ...